Joseph Eid insider trades

Open-market stock purchases and sales by Joseph Eid, EVP, R&D; Chief Medical Office at Geron Corp, from SEC Form 4 filings since Dec 1, 2019.

Recent trades

DateStockTradeValue
Feb 17, 2026GERN Geron CorpBought (not open market)—

Companies traded

  • GERN Geron Corp: other filings, last Feb 17, 2026
  • BMY Bristol Myers Squibb Co: 2 sales, last Jun 3, 2021

Get free alerts when Joseph Eid files a new trade →